Pelitrexol
Alternative Names: AG 2037Latest Information Update: 12 Aug 2008
At a glance
- Originator Pfizer
- Class Antineoplastics; Small molecules; Thiophenes
- Mechanism of Action Phosphoribosylglycinamide formyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Colorectal cancer; Non-small cell lung cancer
Most Recent Events
- 12 Aug 2008 No development reported - Phase-II for Colorectal cancer in USA (IV)
- 12 Aug 2008 No development reported - Phase-II for Non-small cell lung cancer in USA (IV)
- 02 Aug 2006 Pfizer has completed two phase II trials in colorectal and non-small cell lung cancer in the US